Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of April 2021.

The challenges of completing real-world performance review should not slow the FDA’s plans to regulate clinical algorithms.
